NGIO does not have the valuation for listing on NASDAQ without a vaccine. Therefore GNBT does not have the valuation for uplist without the vaccine. If we do not get concrete vaccine news, test results, IND submitted, there is NOTHING that will keep the pps from tanking.
Joe cannot continue to kick the can down the road by inserting fake milestones and additional steps that “we should have known about” all while diluting is on a slow drip.
Make no mistake, this CC is make or break and for me as a shareholder and voter it is Joes last straw.
(8)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links